MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

Search

Prometheus Biosciences Inc

Geschlossen

0

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

Max

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+0.04% upside

Prometheus Biosciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Jan. 2026, 21:55 UTC

Ergebnisse

Capital One Financial Posts Higher 4Q Profit As Lending Increases

22. Jan. 2026, 23:52 UTC

Ergebnisse

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

22. Jan. 2026, 23:48 UTC

Market Talk

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

22. Jan. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Profit-Taking -- Market Talk

22. Jan. 2026, 23:40 UTC

Market Talk

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

22. Jan. 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22. Jan. 2026, 23:30 UTC

Market Talk

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

22. Jan. 2026, 22:37 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

22. Jan. 2026, 21:59 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

22. Jan. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

22. Jan. 2026, 21:44 UTC

Ergebnisse

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

22. Jan. 2026, 21:32 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

22. Jan. 2026, 21:31 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

22. Jan. 2026, 21:31 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

22. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

22. Jan. 2026, 21:30 UTC

Ergebnisse

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

22. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One To Acquire Brex >COF

22. Jan. 2026, 21:13 UTC

Ergebnisse

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

22. Jan. 2026, 21:11 UTC

Ergebnisse

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22. Jan. 2026, 21:11 UTC

Ergebnisse

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22. Jan. 2026, 21:10 UTC

Ergebnisse

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22. Jan. 2026, 21:06 UTC

Ergebnisse

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Rev $15.58B >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q EPS $3.26 >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Net Interest Margin 8.26% >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Net $2.13B >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Adj EPS $3.86 >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Net Charge-Offs $3.8B >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q EPS $2.21 >ISRG

Peer-Vergleich

Kursveränderung

Prometheus Biosciences Inc Prognose

Kursziel

By TipRanks

0.04% Vorteil

12-Monats-Prognose

Durchschnitt 200 USD  0.04%

Hoch 200 USD

Tief 200 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Prometheus Biosciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

7 ratings

0

Buy

7

Halten

0

Sell

Finanzen

$

help-icon Live chat